MindWalk Holdings Corp. (NASDAQ: HYFT) has launched ReefIQ™, a new biological context layer aimed at enhancing AI-driven drug discovery and biologics development. ReefIQ™ addresses the challenge of fragmented biological data by transforming it into a governed, queryable format, enabling AI workflows to reason over connected context rather than isolated files. This system, built on MindWalk's proprietary HYFT® technology, is designed to preserve valuable program insights and integrate with AI models like LensAI™ to generate more trustworthy hypotheses and accelerate drug development.
In life-sciences AI, the durable advantage is not the model a team licenses but the biological context it can reason over. Biology is connected by evolutionary constraint; discovery data arrives fragmented across files and systems, and that gap is where insight is lost. ReefIQ is designed to close it, preserving what every program learns, including the programs that fail, as governed context rather than isolated files. In a regulated setting, that is what makes reasoning trustworthy, and trustworthy is what compounds into the clinic,
— Dr. Jennifer Bath
ReefIQ operationalizes the HYFT information network for drug discovery. HYFT provides the biological representation foundation, representing the complex relationships in biology; ReefIQ links customer data to that foundation and exposes governed context to LensAI and customer-selected agent models operating within agreed governance. The goal is to support retrieval, analysis, and hypothesis generation over connected biological context while preserving provenance, deployment flexibility, and customer-defined controls.
— Dirk Van Hyfte